# Alexander Hein

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alexander-hein/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,695 |
| Field | Ovarian cancer diagnosis and treatment |
| h-index | 53 |
| i10-index | 147 |
| Last Known Institution | Klinikum Esslingen |
| OpenAlex ID | https://openalex.org/A5086392926 |
| ORCID iD | https://orcid.org/0000-0003-2601-3398 |
| Works | 418 |

## Researcher papers

- [Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk](https://scholariq.org/papers/common-genetic-variation-in-cellular-transport-genes-and-epithelial-ovarian/)
- [Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer](https://scholariq.org/papers/dose-response-association-of-cd8-sup-sup-tumor-infiltrating-lymphocytes-and/)
- [GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer](https://scholariq.org/papers/gwas-meta-analysis-and-replication-identifies-three-new-susceptibility-loci-for/)
- [Identification of Novel Genetic Markers of Breast Cancer Survival](https://scholariq.org/papers/identification-of-novel-genetic-markers-of-breast-cancer-survival/)
- [ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer](https://scholariq.org/papers/abca-transporter-gene-expression-and-poor-outcome-in-epithelial-ovarian-cancer/)
- [Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial](https://scholariq.org/papers/bevacizumab-and-platinum-based-combinations-for-recurrent-ovarian-cancer-a/)
- [Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study](https://scholariq.org/papers/association-of-vitamin-d-levels-and-risk-of-ovarian-cancer-a-mendelian/)

## Researcher topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Researcher university

- [Klinikum Esslingen](https://scholariq.org/institutions/klinikum-esslingen/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.